Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: ALEC) | Delayed: 1.88 -0.09 (4.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.97 | 52 Week High | $ | |||
| Open | $1.97 | 52 Week Low | $ | |||
| Day High | $2.00 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $ | |||
| Volume | 542,045 | |||||
